Article and Video CATEGORIES

Cancer Journey

Search By

Managing Three Compartments in Stage III Disease (Local, Distant, CNS)
Sat, 02/06/2016 - 06:00
Author
GRACE Videos and Articles
Image
GRACE Cancer Video Library - Lung

 

Dr. Mark Socinski, University of Pittsburgh Medical Center, defines the three compartments in stage III (locally advanced) NSCLC, each of which must be treated.

 

Transcript

When I see a patient with stage III disease, I am thinking about how I’m going to potentially cure these patients, because I believe, in a good performance status patient, the long term goal should be a cure of the disease. Now, having said that, there are three major compartments that I am concerned about in this patient population.

As I say to my patients, we have to first devise a strategy that’s going to control and eradicate the disease in the chest — obviously, in stage III disease you typically have a lung primary with mediastinal involvement — and what’s the best strategy to eradicate the disease that you can see in the chest?

The second issue is, almost all patients with stage III disease have what we refer to as micrometastatic disease. You have to think about controlling the systemic micrometastatic disease, and that really falls under the responsibility of systemic chemotherapy, in this particular setting.

So, local/regional control and distant systemic control are the first two issues. A third issue in this patient population is the central nervous system. We know that if we control the first two compartments effectively and seemingly, potentially cure a patient, that up to a third of patients may relapse in the brain itself. Some of those patients with limited relapse and aggressive brain treatment can be salvaged at this point, but it is a huge challenge.

There is some evidence that whole brain radiotherapy, prophylactically, can reduce that risk. However, it’s not clear that it leads to an overall survival advantage, so it’s not considered part of the standard of care, and there are many issues about how to adequately follow patients: how often should you go looking for recurrence in the brain with MRI screening and that sort of thing. So, there are no agreed upon guidelines for this, however, I think each individual physician kind of has their own guidelines in terms of how often they would check an MRI to see if they can diagnose CNS disease early, and perhaps eradicate it with the usual treatments we have for that condition. Of course, that would render the patient stage IV at that time, which really is a whole other set of circumstances that we deal with.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Mandarin LCVL
Video
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit: https://www.youtube.com/playlist?list=PLWsyUmdjLXhGnSxobmz4CBP3pxAj7nDa…;  
Image
Tell your story!  Apply now for the Clinical Trials Experiences through Storytelling Program
Article
We are excited to launch our third year of this program; tell your story and help us help others! Apply Online Now!     GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview  
Image
Blood Cancer OncTalk
Video
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.

Forum Discussions

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Recent Comments

JOIN THE CONVERSATION
Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
Concerned
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29